ID   SAL2
AC   CVCL_F122
SY   SAL-2
DR   IARC_TP53; 23640
DR   Wikidata; Q54952084
RX   PubMed=8378080;
RX   PubMed=9393981;
RX   PubMed=15192123;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S862 ! SAL1
OI   CVCL_9681 ! STA-ET-1
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 12
//
RX   PubMed=8378080;
RA   Kovar H., Auinger A., Jug G., Aryee D.N.T., Zoubek A.,
RA   Salzer-Kuntschik M., Gadner H.;
RT   "Narrow spectrum of infrequent p53 mutations and absence of MDM2
RT   amplification in Ewing tumours.";
RL   Oncogene 8:2683-2690(1993).
//
RX   PubMed=9393981; DOI=10.1038/sj.onc.1201397;
RA   Kovar H., Jug G., Aryee D.N.T., Zoubek A., Ambros P.F., Gruber B.,
RA   Windhager R., Gadner H.;
RT   "Among genes involved in the RB dependent cell cycle regulatory
RT   cascade, the p16 tumor suppressor gene is frequently lost in the Ewing
RT   family of tumors.";
RL   Oncogene 15:2225-2232(1997).
//
RX   PubMed=15192123; DOI=10.1158/1541-7786.296.2.5;
RA   Pospisilova S., Siligan C., Ban J., Jug G., Kovar H.;
RT   "Constitutive and DNA damage inducible activation of pig3 and MDM2
RT   genes by tumor-derived p53 mutant C277Y.";
RL   Mol. Cancer Res. 2:296-304(2004).
//